Literature DB >> 14527520

Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.

Nathalie Courret1, Thierry Lang, Geneviève Milon, Jean Claude Antoine.   

Abstract

In order to simulate the natural long term parasitisms which may occur in mammals infected with Leishmania, cutaneous leishmaniases due to Leishmania major or Leishmania amazonensis were induced using a model based on the inoculation of 10-1000 metacyclic promastigotes into the ear dermis of BALB/c mice. The final outcome of these parasitisms was dependent upon the number of inoculated parasites. Only some of the mice inoculated with ten parasites displayed cutaneous lesions, whereas most mice infected with 100 metacyclics and all mice infected with 1000 metacyclics developed progressive lesions. We found, using the latter experimental conditions, that the onset of the pathology was associated with: (a) parasite multiplication in the inoculation site and the draining lymph node correlating with an increase of the lymph node cell number, especially in L. major-infected mice; and (b) the detection of lymph node cells, at least in part CD4(+) T lymphocytes, able to produce high levels of interferon-gamma, interleukin (IL)-4, IL-10 and IL-13. Thereafter, mice infected by L. major harboured few parasites in the ear and had a 100-fold reduction in lymph node parasite load between 23 and 40 weeks post-inoculation. In contrast, the parasite loads of L. amazonensis-infected mice remained stable in the ear and increased in nodes during the same period of time. Only L. major-infected mice that exhibited cutaneous lesions in the primary site were resistant to the re-inoculation of 1000 metacyclic promastigotes, whereas all L. amazonensis-primary infected mice remained susceptible to a second homologous challenge. These results are the first to document that a status of resistance to re-infection, referred to concomitant immunity, is coupled to the development of primary progressive lesions in L. major-infected BALB/c mice. Such a protective status is absent in L. amazonensis-infected BALB/c mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14527520     DOI: 10.1016/s0020-7519(03)00179-6

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  16 in total

Review 1.  Noninvasive biophotonic imaging for studies of infectious disease.

Authors:  Nuria Andreu; Andrea Zelmer; Siouxsie Wiles
Journal:  FEMS Microbiol Rev       Date:  2010-10-19       Impact factor: 16.408

2.  Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis.

Authors:  Tatiana R de Moura; Fernanda O Novais; Fabiano Oliveira; Jorge Clarêncio; Almério Noronha; Aldina Barral; Claudia Brodskyn; Camila I de Oliveira
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hypersensitivity in BALB/c mice.

Authors:  Hamid Mahmoudzadeh-Niknam; Simin Sadat Kiaei; Davood Iravani
Journal:  Korean J Parasitol       Date:  2007-06       Impact factor: 1.341

4.  BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge.

Authors:  Laura Ramírez; Salvador Iborra; Jimena Cortés; Pedro Bonay; Carlos Alonso; Manoel Barral-Netto; Manuel Soto
Journal:  J Biomed Biotechnol       Date:  2010-01-26

5.  Real-time in vivo green fluorescent protein imaging of a murine leishmaniasis model as a new tool for Leishmania vaccine and drug discovery.

Authors:  Sanjay R Mehta; Robert Huang; Meng Yang; Xing-Quan Zhang; Bala Kolli; Kwang-Poo Chang; Robert M Hoffman; Yasuyuki Goto; Roberto Badaro; Robert T Schooley
Journal:  Clin Vaccine Immunol       Date:  2008-10-22

6.  Complement receptor 3 deficiency influences lesion progression during Leishmania major infection in BALB/c mice.

Authors:  Cristina R Carter; James P Whitcomb; Jessica A Campbell; Rami M Mukbel; Mary Ann McDowell
Journal:  Infect Immun       Date:  2009-09-21       Impact factor: 3.441

7.  Distinct transcriptional signatures of bone marrow-derived C57BL/6 and DBA/2 dendritic leucocytes hosting live Leishmania amazonensis amastigotes.

Authors:  Emilie Giraud; Hervé Lecoeur; Guillaume Soubigou; Jean-Yves Coppée; Geneviève Milon; Eric Prina; Thierry Lang
Journal:  PLoS Negl Trop Dis       Date:  2012-12-13

Review 8.  Visceral leishmaniasis: experimental models for drug discovery.

Authors:  Suman Gupta
Journal:  Indian J Med Res       Date:  2011-01       Impact factor: 2.375

9.  Modeling of leishmaniasis infection dynamics: novel application to the design of effective therapies.

Authors:  Bettina M Länger; Cristina Pou-Barreto; Carlos González-Alcón; Basilio Valladares; Bettina Wimmer; Néstor V Torres
Journal:  BMC Syst Biol       Date:  2012-01-05

10.  Reprogramming neutral lipid metabolism in mouse dendritic leucocytes hosting live Leishmania amazonensis amastigotes.

Authors:  Hervé Lecoeur; Emilie Giraud; Marie-Christine Prévost; Geneviève Milon; Thierry Lang
Journal:  PLoS Negl Trop Dis       Date:  2013-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.